BeOne Medicines (BEIGF) Net Margin Growth (1y) (2016 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Net Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.95 Bn | 625.20 Bn | 17.26 Bn | -146.00 |
| 2 | AbbVie | 441.39 Bn | 434.82 Bn | 12.70 Bn | 1,518.00 |
| 3 | Merck | 366.72 Bn | 359.58 Bn | 12.21 Bn | -3,607.00 |
| 4 | Novartis Ag | 266.68 Bn | 258.99 Bn | 11.24 Bn | -610.00 |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -2,157.00 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -3,647.00 |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 8 | Incyte | 25.50 Bn | 20.96 Bn | 1.57 Bn | 166.00 |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | 376.00 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 673.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 673.00 |
| Mar 31, 2026 | 1,491.00 |
| Dec 31, 2025 | 1,791.00 |
| Sep 30, 2025 | 2,096.00 |
| Jun 30, 2025 | 2,013.00 |
| Mar 31, 2025 | 3,353.00 |
| Dec 31, 2024 | 4,447.00 |
| Sep 30, 2024 | -3,969.00 |
| Jun 30, 2024 | 5,107.00 |
| Mar 31, 2024 | 4,440.00 |
| Dec 31, 2023 | 5,923.00 |
| Sep 30, 2023 | 17,141.00 |
| Jun 30, 2023 | 10,160.00 |
| Mar 31, 2023 | 6,412.00 |
| Dec 31, 2022 | 15,888.00 |
| Sep 30, 2022 | 6,839.00 |
| Jun 30, 2022 | 15,462.00 |
| Mar 31, 2022 | -15,291.00 |
| Dec 31, 2021 | 22,417.00 |
| Sep 30, 2021 | 25,617.00 |